Protein kinetic signatures of the remodeling heart following isoproterenol stimulation

Journal of Clinical Investigation

Volumn 124, Issue 4, 2014, Pages 1734-1744

  Lam, Maggie P Y ^a,b   Wang, Ding ^a,b   Lau, Edward ^a,b   Liem, David A ^a,b   Kim, Allen K ^a,b   Ng, Dominic C M ^a,b   Liang, Xiangbo ^a,b   Bleakley, Brian J ^a,b   Liu, Chenguang ^a,b   Tabaraki, Jason D ^b   Cadeiras, Martin ^a   Wang, Yibin ^a,b   Deng, Mario C ^a   Ping, Peipei ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DEUTERIUM OXIDE; ISOPRENALINE; MITOCHONDRIAL PROTEIN; PROTEOME;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM SIGNALING; HEART DISEASE; HEART EJECTION FRACTION; HEART REMODELING; HEART WEIGHT; HUMAN; IMMUNOBLOTTING; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; LONGITUDINAL STUDY; MALE; MASS SPECTROMETRY; MITOCHONDRIAL DYNAMICS; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; PROTEIN KINETICS; PROTEIN LOCALIZATION; PROTEIN METABOLISM; QUANTITATIVE ANALYSIS; RIBOSOME SUBUNIT;

ADRENERGIC BETA-AGONISTS; ADULT; ANIMALS; CALCIUM SIGNALING; DEUTERIUM OXIDE; HEART; HEART FAILURE; HUMANS; ISOPROTERENOL; KINETICS; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED ICR; MITOCHONDRIA, HEART; MUSCLE PROTEINS; MYOCARDIUM; PROTEINS;

EID: 84897493699     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI73787     Document Type: Article

References (50)

1. Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science. 2008;319(5865):916-919. (Pubitemid 351263754)
2. Hinkson IV, Elias JE. The dynamic state of protein turnover: It's about time. Trends Cell Biol. 2011;21(5):293-303.
3. Claydon AJ, Beynon R. Proteome dynamics: revisiting turnover with a global perspective. Mol Cell Proteomics. 2012;11(12):1551-1565.
4. Katz AM. Physiology of the Heart. 5th ed. Philadelphia, Pennsylvania, USA: Lippincott Williams & Wilkins; 2010.
5. Goonasekera SA, et al. Decreased cardiac L-type Ca(2) (+) channel activity induces hypertrophy and heart failure in mice. J Clin Invest. 2012;122(1):280-290.
6. Tsutsui H, Kinugawa S, Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res. 2009;81(3):449-456.
7. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest. 2005;115(3):500-508. (Pubitemid 40322219)
8. Wang X, Li J, Zheng H, Su H, Powell SR. Proteasome functional insufficiency in cardiac pathogenesis. Am J Physiol Heart Circ Physiol. 2011;301(6):H2207-H2219.
9. Abel ED, Doenst T. Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. Cardiovasc Res. 2011;90(2):234-242.
10. Drews O, Tsukamoto O, Liem D, Streicher J, Wang Y, Ping P. Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophy. Circ Res. 2010;107(9):1094-1101.
11. Dai DF, et al. Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress. Cardiovasc Res. 2012;93(1):79-88.
12. Doherty MK, Beynon RJ. Protein turnover on the scale of the proteome. Expert Rev Proteomics . 2006;3(1):97-110. (Pubitemid 43979395)
13. Varshavsky A. The N-end rule pathway and regulation by proteolysis [published online ahead of print June 1, 2011]. Protein Sci. doi:10.1002/pro.666.
14. Schwanhausser B, et al. Global quantification of mammalian gene expression control. Nature. 2011;473(7347):337-342.
15. Khmelinskii A, et al. Tandem fluorescent protein timers for in vivo analysis of protein dynamics. Nat Biotechnol. 2012;30(7):708-714.
16. Kim TY, et al. Metabolic labeling reveals proteome dynamics of mouse mitochondria. Mol Cell Proteomics. 2012;11(12):1586-1594.
17. Rachdaoui N, et al. Measuring proteome dynamics in vivo: as easy as adding water? Mol Cell Proteomics. 2009;8(12):2653-2663.
18. Emson CL, et al. A pilot study demonstrating a non-invasive method for the measurement of protein turnover in skin disorders: application to psoriasis. Clin Transl Med. 2013;2(1):12.
19. Kasumov T, et al. Assessment of cardiac proteome dynamics with heavy water: slower protein synthesis rates in interfibrillar than subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol. 2013;304(9):H1201-H1214.
20. Price JC, et al. Measurement of human plasma proteome dynamics with (2)H(2)O and liquid chromatography tandem mass spectrometry. Anal Biochem. 2012;420(1):73-83.
21. Fanara P, et al. Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J Clin Invest. 2012;122(9):3159-3169.
22. Rockman HA, et al. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci U S A. 1998;95(12):7000-7005. (Pubitemid 28278096)
23. Claydon AJ, Ramm SA, Pennington A, Hurst JL, Stockley P, Beynon R. Heterogenous turnover of sperm and seminal vesicle proteins in the mouse revealed by dynamic metabolic labeling. Mol Cell Proteomics. 2012;11(6):M111.014993.
24. Price JC, Guan S, Burlingame A, Prusiner SB, Ghaemmaghami S. Analysis of proteome dynamics in the mouse brain. Proc Natl Acad Sci U S A. 2010;107(32):14508-14513.
25. Benevolensky D, et al. Expression and localization of the annexins II, V, and VI in myocardium from patients with end-stage heart failure. Lab Invest. 2000;80(2):123-133. (Pubitemid 30120965)
26. Song G, Campos B, Wagoner LE, Dedman JR, Walsh RA. Altered cardiac annexin mRNA and protein levels in the left ventricle of patients with end-stage heart failure. J Mol Cell Cardiol. 1998;30(3):443-451. (Pubitemid 28132724)
27. Gaussin V, et al. Common genomic response in different mouse models of beta-adrenergic-induced cardiomyopathy. Circulation. 2003;108(23):2926-2933. (Pubitemid 37517822)
28. Sheikh F, et al. An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. J Clin Invest. 2008;118(12):3870-3880.
29. van Bilsen M, Smeets PJ, Gilde AJ, van der Vusse GJ. Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? Cardiovasc Res. 2004;61(2):218-226. (Pubitemid 38091762)
30. Kolwicz SC, Kolwicz SC Jr, Tian R. Glucose metabolism and cardiac hypertrophy. Cardiovasc Res. 2011;90(2):194-201.
31. Petrak J, et al. Proteomic and transcriptomic analysis of heart failure due to volume overload in a rat aorto-caval fistula model provides support for new potential therapeutic targets - monoamine oxidase A and transglutaminase 2. Proteome Sci. 2011;9(1):69.
32. Dai DF, et al. Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides. Circ Heart Fail. 2013;6(5):1067-1076.
33. Dorn GW. Mitochondrial dynamics in heart disease. Biochim Biophys Acta. 2013;1833(1):233-241.
34. Gottlieb RA, Gustafsson AB. Mitochondrial turnover in the heart. Biochim Biophys Acta. 2011;1813(7):1295-1301.
35. Lotz C, et al. The characterization, design, and function of the mitochondrial proteome: from organs to organisms [published online ahead of print December 12, 2013]. J Proteome Res. doi:10.1021/pr400539j.
36. Lau E, et al. Substrate- and isoform-specific proteome stability in normal and stressed cardiac mitochondria. Circ Res. 2012;110(9):1174-1178.
37. Hipkiss AR. Energy metabolism and ageing regulation: metabolically driven deamidation of triosephosphate isomerase may contribute to proteostatic dysfunction. Ageing Res Rev. 2011;10(4):498-502.
38. Xu T, et al. ProLuCID, a fast and sensitive tandem mass spectra-based protein identification program. Mol Cell Proteomics. 2006;5:S174.
39. Huttlin EL, et al. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell. 2010;143(7):1174-1189.
40. Nagaraj N, et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol Syst Biol. 2011;7:548.
41. Price JC, et al. The effect of long term calorie restriction on in vivo hepatic proteostatis: a novel combination of dynamic and quantitative proteomics. Mol Cell Proteomics. 2012;11(12):1801-1814.
42. Lindsey ML, et al. A multidimensional proteomic approach to identify hypertrophy-associated proteins. Proteomics. 2006;6(7):2225-2235.
43. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44-57.
44. Zong N, et al. Integration of cardiac proteome biology and medicine by a specialized knowledgebase. Circ Res. 2013;113(9):1043-1053.
45. Chen D-H, et al. A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutations. J Neurol Sci. 2010;296(1-2):22-29.
46. Klauke B, et al. De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy. Hum Mol Genet. 2010;19(23):4595-4607.
47. Hnia K, et al. Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle. J Clin Invest. 2011;121(1):70-85.
48. Hwang KC, Gray CD, Sweet WE, Moravec CS, Im MJ. Alpha 1-adrenergic receptor coupling with Gh in the failing human heart. Circulation. 1996;94(4):718-726. (Pubitemid 26289228)
49. Beuschlein F, et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet. 2013;45(4):440-444.
50. Wang DZ, et al. Requirement of a novel gene, Xin, in cardiac morphogenesis. Development. 1999;126(6):1281-1294.